Difficile
Navigation Links
Difficile in Medical News
ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
EXTON, Pa., Aug. 6 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that dosing has begun in the Phase 1 clinical trial for NTCD (non-toxigenic Clostridium difficile ), a novel treatment approach for preventing recurrent Clostridium difficile infections (...SUNNYVALE, Calif., July 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) C. difficile test, an on-demand molecular diagnostic test designed for 45-minute detection of the bac...
Transmission of MRSA and Clostridium difficile through dogs
London, UK, 7 May 2009 In a letter to the Editor of the Journal of Hospital Infection ( http://www.elsevier.com/locate/jhin ), published by Elsevier, S. Lefebvre and J.S. Weese from the University of Guelph in Canada describe a study that investigated whether MRSA and C.difficile could be pas...Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
Complimentary Continuing Education Virtual Lecture for Healthcare Professionals VOORHEES, N.J., March 23 /PRNewswire/ -- The epidemiology of Clostridium difficile infection (CDI) is changing rapidly and has been marked by a significant increase in incidence and severity. Management of CDI c...Clostridium difficile Infection: Best Strategies for Care of Older Adults
Complimentary Continuing Education Monograph for Registered Nurses and Nurse Practitioners VOORHEES, N.J., Jan. 27 /PRNewswire/ -- Over the past several years, the incidence and mortality rates of Clostridium difficile infection (CDI) have increased dramatically. CDI is a serious condition,...Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals VOORHEES, N.J., Jan. 19 /PRNewswire/ -- Clostridium difficile infection (CDI) is increasingly being seen in older adults, especially among residents of long-term care facilities (LTCFs). This is further compli...SAN DIEGO, Jan. 12 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection of the To...
Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
A Complimentary Continuing Medical Education Newsletter Series for Physicians VOORHEES, N.J., Dec. 17 /PRNewswire/ -- Management of Clostridium difficile infection (CDI) in geriatric and pediatric populations can be challenging and complicated. Because of the observed increase in CDI...MRSA and C. difficile Infections Reduced by 50% in Hospital Study
ROME, N.Y., Dec. 1 /PRNewswire/ -- To help prevent the spread of germs and protect its patients from infections, Rome Memorial Hospital is using two new products that kill germs on hands and surfaces between cleanings. According to Infection Prevention Director LeAnna Grace, the hospital c...Test Simultaneously Identifies and Differentiates More Virulent 027 Strain from Common Strains SUNNYVALE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(TM) C. difficile as a European CE IVD Mark product under the E...
Difficile in Medical Technology
Positive data from subgroup analysis presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Helsinki , Finland
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that the results fr...
BD GeneOhm(TM) Cdiff Assay Submitted for FDA Clearance SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid diagnosis of patie...
Campaign will Arm Infection Prevention Professionals With Guidelines and Tools WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a series of new educational initiatives aimed at eliminati...
Novel Antibiotic Candidate Rapidly Bactericidal Against Both Cultures and Spores of the Anaerobic Bacterium Using Multiple in Vitro Methods CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation today released data from two studies comparing the in vitro activity of its lead anti...
Poster to be Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy LOUISVILLE, Colo., Sept. 19 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN ) announced today that in preclinical studies, its antibacterial candidate REP3123 i...
Poster to be Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy LOUISVILLE, Colo., Sept. 19 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN ) announced today that in preclinical studies, its antibacterial candidate REP3123 i...
CAMBRIDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. announced top-line data today from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic, polymer therapy for patients with Clostridium difficile as...
BD GeneOhm(TM) Cdiff Assay Submitted for FDA Clearance SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid diagnosis of patie...
Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
A Complimentary Continuing Education Newsletter Series for Healthcare Professionals VOORHEES, N.J., July 1 /PRNewswire/ -- Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea ...Campaign will Arm Infection Prevention Professionals With Guidelines and Tools WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a series of new educational initiatives aimed at eliminati...
Novel Antibiotic Candidate Rapidly Bactericidal Against Both Cultures and Spores of the Anaerobic Bacterium Using Multiple in Vitro Methods CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation today released data from two studies comparing the in vitro activity of its lead anti...
Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
LYON, France, February 17 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that it is sponsoring a phase II clinical study of a vaccine against Clostridium difficile, which is among the most common causes o...Poster to be Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy LOUISVILLE, Colo., Sept. 19 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN ) announced today that in preclinical studies, its antibacterial candidate REP3123 i...
Poster to be Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy LOUISVILLE, Colo., Sept. 19 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN ) announced today that in preclinical studies, its antibacterial candidate REP3123 i...
CAMBRIDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. announced top-line data today from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic, polymer therapy for patients with Clostridium difficile as...
Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
...Virginia was selected for her research proposal, "The Influence of Novel Oligopeptides Produced by Transgenic Bacteria on Intestinal Injury Due to C. difficile Infection." After certain inflammatory conditions, drug treatments, or infections, human gut microbiota can become unbalanced. This research will foc...Difficile in Medical Products
Clostridium difficile Toxins (A & B) by EIA
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Company:ARUP Laboratories
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories
Description: The C. Difficile Tox A/B II is a second-generation rapid ELISA for the detection of Clostridium difficile toxins A and B in fecal specimens. The test utilizes highly specific antibodies and produces highly sensitive results detecting not only the more common toxin A+ samples, but also samples that ...
Company:Inverness Medical Innovations
Xpect Clostridium difficile Toxin A/B Test Kit
Description: Remels newest member of the Xpect family, Xpect C. difficile Toxin A/B, detects both Toxin A and B in one rapid test. The simple-to-perform test requires no sample preparation, and results are available in 20 minutes. The Remel Xpect family of rapid diagnostic test kits includes a wide range ...Company:Remel Inc.
Description: The Triage® C. difficile Panel is an enzyme immunoassay used for the detection of C. difficile common antigen (glutamate dehydrogenase) and toxin A in human fecal specimens. This test is used as an aid in the diagnosis of C. difficile associated disease and is part of the Triage Microbiology pr...
Company:Biosite
Bartels® C. Difficile Toxin A Antigen EIA with Controls
Description: Bartels Clostridium difficile Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficile Toxin A in human faecal specimens as an aid in the diagnosis of Clostridium difficile-associated disease....Company:Trinity Biotech
VIDAS Clostridium difficile (Toxin A) assay
Description: VIDAS tests are presented in individual, ready to use form. Each test is composed of a strip and a SPR. The strip contains all the reagent required for the reaction (buffer, conjugate and substrate.) The SPR (Solid Phase Receptacle) is a plastic pippette-like device. Its inside surface is coated...Company:bioMerieux, Inc.
BD ColorPAC Toxin A C. difficile Rapid Toxin A Test
Description: BD ColorPAC Toxin A C. difficile Rapid Toxin A Test gives your laboratory clear-cut results in as little as 10 minutes. When it might be C. difficile, you can't afford to wait. For any laboratory that performs only a few tests a day or sends out its suspected C. difficile samples for testing, Color...Company:BD Diagnostic Systems
Description: ELISA for the detection of C. difficile toxin A in stool specimens...
Company:Meridian Bioscience, Inc.
Clostridium Difficile Toxin A RAPYDTEST®
Description: Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces....Company:DiaSys Corporation
Difficile in Medical Dictionary
...h is needed to link ... ... VA) (Quik Chek), and ImmunoCard Toxins A&B (Meridian Bioscience, Cincinnati, OH) (ImmunoCard) ... of Clostridium difficile toxin : comparison of enzyme ... High-flux hemodialysis (which removes large toxins ) reduces the risk of premature death in many patients w...
.... for Infectious Disease Research And ... Emerging and Re-emerging Infectious Diseases ... Covers infectious diseases (such as Clostridium difficile and MRSA) ... From the publishers of The New England Journal of Medicine. Keeps clinicians up-to-date on the most important research impacting in...
...xins ( enterotoxin /neurotoxin/hemoto xin/cardiotoxin) Bacterial toxins. Exotoxin. Gram positive ... · perfringens (Alpha toxin, Enterotoxin ) · difficile (A, B) ... Definition of enterotoxin from the Merriam-Webster Online Dictionary with audio pronunciations, thesaurus, Word of the Day, and word ...
...ons, but the cramps are really bothering her. ... What is Clostridium difficile colitis?Clostridium difficile (also called C. difficile) are bacteria that can cause ... diarrhea, feve...
...idium , such as the Explains how Clostridium difficile bacteria cause colitis and why patients may su...ne and antibiotic ... What is Clostridium difficile (C. difficile)? What are C. difficile diseases? ... SHEA Position Paper: Clostridium ...
.... for Infectious Disease Research And ... Emerging and Re-emerging Infectious Diseases ... Covers infectious diseases (such as Clostridium difficile and MRSA) ... From the publishers of The New England Journal of Medicine. Keeps clinicians up-to-date on the most important research impacting in...
...xins ( enterotoxin /neurotoxin/hemoto xin/cardiotoxin) Bacterial toxins. Exotoxin. Gram positive ... · perfringens (Alpha toxin, Enterotoxin ) · difficile (A, B) ... Definition of enterotoxin from the Merriam-Webster Online Dictionary with audio pronunciations, thesaurus, Word of the Day, and word ...
...ons, but the cramps are really bothering her. ... What is Clostridium difficile colitis?Clostridium difficile (also called C. difficile) are bacteria that can cause ... diarrhea, feve...
...idium , such as the Explains how Clostridium difficile bacteria cause colitis and why patients may su...ne and antibiotic ... What is Clostridium difficile (C. difficile)? What are C. difficile diseases? ... SHEA Position Paper: Clostridium ...
Difficile in Biological News
C. difficile spores spread superbug
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile , contributing to the outbreaks that have recently been widely reported in hospitals and other settings. A team of scientists have successfully mi...Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck
WHITEHOUSE STATION N.J., PRINCETON, N.J. and JAMAICA PLAIN, Mass., April 21, 2009 Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an...Understanding why C. difficile causes disease -- it's hungry
Researchers studying the genetics behind why C. difficile causes disease have come to a simple conclusion -- the bacteria do it because they are starving. That just might help them find a new treatment for what can sometimes be a very difficult disease to treat. "The genes responsible for toxin...Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates
A study published today in the Journal of Antimicrobial Chemotherapy1 provides the best available evidence that cases of Clostridium difficile infection (CDI)---one of the most common and increasing types of hospital-acquired infection---can be reduced in hospital wards if doctors prescribe narrow-...Antibiotics take toll on beneficial microbes in gut
...d 500,000 to 1 million Americans, and Clostridium difficile , a growing and serious infection problem for hosp...fractory antibiotic-associated diarrhea due to C. difficile , there have been limited trials of treatments usi... to gain insights into colitis associated with C. difficile infection. The Young laboratory recently publishe...Newly discovered reactions from an old drug may lead to new antibiotics
... can halt the growth of the super bug Clostridium difficile and Treponema denticola , a major contributor to gum disease. Infections of Clostridium difficile (commonly known as C-diff) lead to a spectrum of ...h of the bacteria. The initial studies with C. difficile led to studies with T. denticola, known for severa...Monash scientists debug superbug
...s to genetically modify the bacterium Clostridium difficile and solved the mystery surrounding its toxicity. ...an a decade. Dr Lyras said strains of Clostridium difficile are found in almost every hospital in Australia. ... that in the US, more people die from Clostridium difficile infections than all other intestinal infections c...Scientists unlock the secrets of C. difficile's protective shell
... 'jacket' that surrounds cells of the Clostridium difficile superbug, and which helps the dangerous pathogen ...reveal possible targets for new drugs to treat C. difficile infections. The 'jacket' is a surface layer, o...ns, with half a million of each covering every C. difficile cell. The S-layer is believed to help C....Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
...oday announced that a Phase 2 trial of an anti- C. difficile antibody combination treatment in patients with C. difficile Associated Diarrhea (CDAD) successfully met its p...1), two fully human antibodies that neutralize C. difficile toxins A and B, respectively. Consistent with ...UV lotion lights the way to cleaner facilities
...ow that spores from the nasty bacteria Clostridium difficile (C. difficile) linger in the loo even when it has ...llin resistant Staphylococcus aureus (MRSA) and C. difficile because they are not eradicated from the hospital ...spital in Winnipeg. Seven of these patients had C. difficile infection, while 13 others did not. The toilets an...Difficile in Biological Technology
NEWARK, N.J., July 21 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology based Life Science Company announced today that at ATS Labs using the required EPA protocol testing, BioNeutral's Ygiene(TM) Hospital Grade Antimic...
NEWARK, N.J., July 9 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that at ATS Labs, using a Quantitative Disk Carrier test starting with 5.5 million Clostridium Difficile (C.diff) spores...
Top-line data from randomized, double-blind, placebo controlled Phase 2 clinical trial indicate statistically significant reduction in recurrences of CDAD PRINCETON, N.J. and JAMAICA PLAIN, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) a...
...e and important applications of Ygiene(TM) come to mind: 1- Perhaps the biggest challenge facing hospitals worldwide is eradication of Clostridium difficile spores in the environment in a timely fashion thereby reducing or eliminating possible nosocomial spread. Ygiene(TM) safely and efficiently solves th...
NEWARK, N.J., July 9 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that at ATS Labs, using a Quantitative Disk Carrier test starting with 5.5 million Clostridium Difficile (C.diff) spores...
Clostridium difficile Infection: Strategic Approaches for Better Outcomes
Complimentary Continuing Education Live Lectures for Healthcare Professionals VOORHEES, N.J., June 15 /PRNewswire/ -- In recent years, the epidemiology of Clostridium difficile infection (CDI) has been changing. This trend may be the result of antimicrobial use, infection control practices,...Clostridium difficile Infection: Current Challenges and Controversies
Complimentary Continuing Education Virtual Lecture and Podcast for Healthcare Professionals VOORHEES, N.J., Jan. 20 /PRNewswire/ -- Current education about Clostridium difficile infection (CDI) is critical for several reasons. The epidemiology of CDI is changing and has been marked by incre...Top-line data from randomized, double-blind, placebo controlled Phase 2 clinical trial indicate statistically significant reduction in recurrences of CDAD PRINCETON, N.J. and JAMAICA PLAIN, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) a...
Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
...omicin North American Phase 3 clinical study for patients with Clostridium difficile infection at the European Congress of Clinical Microbiology and Infectious...herapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed two Phase 3...Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
...evelopment. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infect......e and important applications of Ygiene(TM) come to mind: 1- Perhaps the biggest challenge facing hospitals worldwide is eradication of Clostridium difficile spores in the environment in a timely fashion thereby reducing or eliminating possible nosocomial spread. Ygiene(TM) safely and efficiently solves th...
Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
...f the platform technology and more recently the C. difficile programme. New anti-infective drugs are needed to target C. difficile without depleting other beneficial bacteria in the...at Novacta's lead lantibiotics selectively kill C. difficile with less disturbance of normal gut bacteria than ...Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
...evelopment. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infect...Other TagsmobilizecapturecapturecapturecaptureIgGIgGIgGIgGburpaggravategastrogastrogastrosmallericyicyicyicyOther Contentshistonehistonehistonehistonehistonehistonehomeoboxhomeostasishomeostasishomeostasishomeostasisconvergentconvergentconvergentconvergenthomozygotehomozygotehormonehormonehormonehormonehormonehormonehormonehormonehormone
(Date:11/27/2009)...wswire/ -- Considered a highly risky and controver...gan transplantation is now a life-saving mainstrea...men who gathered at the Winspear Opera House in Da...l centers around the world to celebrate the 25th a... (BRTI), one of the pioneers of solid organ transp...
(Date:11/27/2009).... 27 Team Garmin-Slipstream, the e...to ethical sporting and developing the next genera... will become Team Garmin-Transitions with the addi...e team. Transitions Optical is the world,s leading...st advanced photochromic technology in the widest ...
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] More Foot Power, Less Car Pollution Best for Health[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
(Date:11/25/2009)...y lives. In addition to mammalian immune systems t...lled bacteriophages, viruses that kill half the ba...ia and another class of microorganisms called arch... as deep-sea volcanic vents) manage just fine, tha...se system that helps protect them from many viruse...
(Date:11/25/2009)... is the linchpin of the environment, where atmosph..., many students see soil as "just dirt" a place t...ators are challenged with the task of helping stud...nce of soil in the environment. , A collaborati...ers at University of Nebraska-Lincoln, Oregon Stat...
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Feeding the clock 2Feeding the clock 3CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3New Drug Could Work Against Leukemia 50663 1| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |